speb/financial-data huggingface dataset:
Financial ratios for CB1A.DE — quarterly report dated 2025-05-31
Total revenue: 2677500000
Gross profit: 1266600000
Operating income: 765900000
Net income: 523800000
Capital expenditures: 192800000
Operating cash flow: 637200000
Depreciation & amortization: 105200000
Net tangible assets: -424800000
Owner earnings: 436200000
Return on net tangible assets (%): -102.68361581920904
Capex to operating income (%): 25.172999086042562
Buffett classification: The Good
Stock price: 236.35051546391753
P/E ratio: 19.261857575223484
Shares outstanding: 170752511
Book value: 7532100000
P/B ratio: 5.358060035263506
Market cap (USD): 40357443991.608246
Debt to equity: 1.5356938967884122
Current ratio: 1.066917517121897
Quick ratio: 0.6847134620069841
Effective tax rate (%): 14.327772325809619
Interest coverage ratio: 7.613320079522863
COGS to revenue (%): 46.625583566760035
SG&A to revenue (%): 18.70028011204482
Free cash flow (dilution-adjusted): 434000000
Buyback yield (%): 0.758472216584502
Retained earnings: 12938900000
Inventory turnover: 0.8841985976343933
Receivables turnover: 3.2921431206196976
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.124705147399373
FCF margin (%): 16.209150326797385
Revenue growth (%): 15.773770917109871
Rule of 40 score: 31.982921243907256
Financial ratios for CB1A.DE — quarterly report dated 2025-08-31
Total revenue: 2653900000
Gross profit: 1310000000
Operating income: 874000000
Net income: 486100000
Capital expenditures: 217300000
Operating cash flow: 852100000
Depreciation & amortization: 102700000
Net tangible assets: -212300000
Owner earnings: 371500000
Return on net tangible assets (%): -174.98822421102213
Capex to operating income (%): 24.862700228832953
Buffett classification: The Great
Stock price: 236.35051546391753
P/E ratio: 63.12755199688448
Shares outstanding: 170752511
Book value: 7786300000
P/B ratio: 5.183134992436491
Market cap (USD): 40357443991.608246
Debt to equity: 1.3542889434005883
Current ratio: 1.0825374144543882
Quick ratio: 0.5411747010603896
Effective tax rate (%): 37.91033337591008
Interest coverage ratio: 9.820224719101123
COGS to revenue (%): 44.12374241682053
SG&A to revenue (%): 16.428652172274766
Free cash flow (dilution-adjusted): 613100000
Buyback yield (%): 0.7381537841245448
Retained earnings: 13225500000
Inventory turnover: 0.8133638952559561
Receivables turnover: 2.8053911205073994
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 4.658848614072494
FCF margin (%): 23.101850107389126
Revenue growth (%): -0.8814192343604109
Rule of 40 score: 22.220430873028715
Financial ratios for CB1A.DE — quarterly report dated 2025-11-30
Total revenue: 2374400000
Gross profit: 1183200000
Operating income: 692000000
Net income: 522200000
Capital expenditures: 246000000
Operating cash flow: 616900000
Depreciation & amortization: 99000000
Net tangible assets: -12500000
Owner earnings: 375200000
Return on net tangible assets (%): -3001.6
Capex to operating income (%): 35.54913294797688
Buffett classification: The Good
Stock price: 134.48837209302326
P/E ratio: 19.771181433651353
Shares outstanding: 170752511
Book value: 8000300000
P/B ratio: 2.87042076361962
Market cap (USD): 22964227235.186047
Debt to equity: 1.3329250153119259
Current ratio: 1.3386250690226393
Quick ratio: 0.7039849070495122
Effective tax rate (%): 17.412620591491383
Interest coverage ratio: 7.990762124711316
COGS to revenue (%): 43.78369272237197
SG&A to revenue (%): 20.68733153638814
Free cash flow (dilution-adjusted): 355000000
Buyback yield (%): 0.9584472307553216
Retained earnings: 13550400000
Inventory turnover: 0.75377030162413
Receivables turnover: 3.352251870676267
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.546862666707671
FCF margin (%): 14.951145552560646
Revenue growth (%): -10.531670371905498
Rule of 40 score: 4.419475180655148
Financial ratios for CB1A.DE — quarterly report dated 2026-02-28
Total revenue: 2049700000
Gross profit: 951700000
Operating income: 531200000
Net income: 224700000
Capital expenditures: 218900000
Operating cash flow: 562800000
Depreciation & amortization: 111800000
Net tangible assets: 315500000
Owner earnings: 117600000
Return on net tangible assets (%): 37.27416798732171
Capex to operating income (%): 41.20858433734939
Buffett classification: The Good
Stock price: 155.8470588235294
P/E ratio: 15.147584600456712
Shares outstanding: 170752511
Book value: 8386900000
P/B ratio: 3.172957424803247
Market cap (USD): 26611276626.08235
Debt to equity: 1.335725953570449
Current ratio: 1.080489255706744
Quick ratio: 0.5474012937764889
Effective tax rate (%): 36.01936218678816
Interest coverage ratio: 6.220140515222482
COGS to revenue (%): 47.25081719275991
SG&A to revenue (%): 20.515197345953066
Free cash flow (dilution-adjusted): 324200000
Buyback yield (%): 0.3757805437338079
Retained earnings: 13574400000
Inventory turnover: 0.6754306436990027
Receivables turnover: 2.163728491502164
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.7651256851650383
FCF margin (%): 15.816948821778798
Revenue growth (%): -13.675033692722371
Rule of 40 score: 2.141915129056427
Financial ratios for CB1A.DE — annual report dated 2026-02-28
Total revenue: 9755500000
Gross profit: 4711500000
Operating income: 2863100000
Net income: 1756800000
Capital expenditures: 875000000
Operating cash flow: 2669000000
Depreciation & amortization: 418700000
Net tangible assets: 315500000
Owner earnings: 1300500000
Return on net tangible assets (%): 412.202852614897
Capex to operating income (%): 30.561279731759285
Buffett classification: The Good
Stock price: 155.8470588235294
P/E ratio: 15.147584600456712
Shares outstanding: 170752511
Book value: 8386900000
P/B ratio: 3.172957424803247
Market cap (USD): 26611276626.08235
Debt to equity: 1.335725953570449
Current ratio: 1.080489255706744
Quick ratio: 0.5474012937764889
Effective tax rate (%): 26.116578349735047
Interest coverage ratio: 7.917865044247788
COGS to revenue (%): 45.384654810107115
SG&A to revenue (%): 18.94726051970683
Free cash flow (dilution-adjusted): 1726300000
Buyback yield (%): 3.4725880046441193
Retained earnings: 13574400000
Inventory turnover: 3.0877327568170725
Receivables turnover: 10.298215982265386
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.903673473637088
FCF margin (%): 17.69565885910512
Revenue growth (%): -10.964780184176181
Rule of 40 score: 6.730878674928938
Financial ratios for CNS.L — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 0.0017567567567567566
Shares outstanding: 512165134
Market cap (USD): 899749.5597297297
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNS.L — annual report dated 2022-12-31
Total revenue: 24242168.674698796
Gross profit: 21138554.21686747
Operating income: 814457.8313253012
Net income: 667469.8795180724
Capital expenditures: 506024.0963855422
Operating cash flow: -2083132.530120482
Depreciation & amortization: 2786746.987951807
Net tangible assets: 2880722.8915662654
Owner earnings: 2948192.7710843375
Return on net tangible assets (%): 102.34211626934338
Capex to operating income (%): 62.130177514792905
Buffett classification: The Good
Stock price: 0.0010843373493975904
P/E ratio: 0.832037221299639
Shares outstanding: 512165134
Book value: 19137349.39759036
P/B ratio: 0.029019681478217076
Market cap (USD): 555359.7838554217
Debt to equity: 0.08096197431377487
Current ratio: 1.5219740634005763
Quick ratio: 1.502281460134486
Effective tax rate (%): -37.12871287128713
Interest coverage ratio: 2.4229390681003586
COGS to revenue (%): 12.80254460513891
Free cash flow (dilution-adjusted): -5107228.915662651
Buyback yield (%): 0
Retained earnings: -95921686.74698795
Inventory turnover: 15.707317073170731
Receivables turnover: 18.857544517338333
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 3.6528693396736194
FCF margin (%): -21.06754137468317
Rule of 40 score: -21.06754137468317
Financial ratios for CNS.L — annual report dated 2023-12-31
Total revenue: 28289873.417721517
Gross profit: 25550632.911392406
Operating income: -20253.164556962023
Net income: -215189.8734177215
Capital expenditures: 1027848.1012658228
Operating cash flow: 3962025.3164556962
Depreciation & amortization: 2588607.594936709
Net tangible assets: 3703797.46835443
Owner earnings: 1345569.6202531646
Buffett classification: The Gruesome
Stock price: 0.0010126582278481013
Shares outstanding: 512165134
Book value: 21186075.949367084
P/B ratio: 0.024480618223098532
Market cap (USD): 518648.23696202534
Debt to equity: 0.018820577164366376
Current ratio: 1.5105983660852287
Quick ratio: 1.5
Interest coverage ratio: -0.08839779005524862
COGS to revenue (%): 9.68275985502707
Free cash flow (dilution-adjusted): 330379.74683544296
Buyback yield (%): 0
Retained earnings: -100993670.88607594
Inventory turnover: 22.541666666666668
Receivables turnover: 9.797895659798334
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): -0.08256786046031583
FCF margin (%): 1.1678374871358894
Revenue growth (%): 16.696958087117235
Rule of 40 score: 17.864795574253122
Financial ratios for CNS.L — annual report dated 2024-12-31
Total revenue: 30698750
Gross profit: 28031250
Operating income: 615000
Net income: 622500
Capital expenditures: 986250
Operating cash flow: 4107500
Depreciation & amortization: 2781250
Net tangible assets: 4063750
Owner earnings: 2417500
Return on net tangible assets (%): 59.48938788065211
Capex to operating income (%): 160.3658536585366
Buffett classification: The Gruesome
Stock price: 0.0025
P/E ratio: 2.0568880883534137
Shares outstanding: 512165134
Book value: 23330000
P/B ratio: 0.054882676168024
Market cap (USD): 1280412.835
Debt to equity: 0.00803686240891556
Current ratio: 1.5040254799610724
Quick ratio: 1.4696098380960807
Effective tax rate (%): 10.09009009009009
Interest coverage ratio: 13.666666666666666
COGS to revenue (%): 8.689278879433202
Free cash flow (dilution-adjusted): -1471250
Buyback yield (%): 0
Retained earnings: -99108750
Inventory turnover: 5.4858611825192805
Receivables turnover: 6.0002443195699975
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 2.216915243545262
FCF margin (%): -4.792540412883261
Revenue growth (%): 8.514978298805321
Rule of 40 score: 3.7224378859220604
Financial ratios for CNS.L — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: 4063750
Buffett classification: The Gruesome
Stock price: 0.0025
Shares outstanding: 512165134
Book value: 23330000
P/B ratio: 0.054882676168024
Market cap (USD): 1280412.835
Debt to equity: 0.00803686240891556
Current ratio: 1.5040254799610724
Quick ratio: 1.4696098380960807
Buyback yield (%): 0
Retained earnings: -99108750
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CNS.L — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: 749315.0684931508
Buffett classification: The Gruesome
Stock price: 0.0019178082191780826
Shares outstanding: 512165134
Book value: 22797260.2739726
P/B ratio: 0.043085638000240366
Market cap (USD): 982234.503561644
Debt to equity: 0.03142651123663022
Current ratio: 1.2839044652128766
Quick ratio: 1.2263759086188994
Buyback yield (%): 0
Retained earnings: -111919178.08219178
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COHU — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 38.09
Shares outstanding: 47175347
Market cap (USD): 1796908967.2300003
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COHU — annual report dated 2022-12-31
Total revenue: 812775000
Gross profit: 383326000
Operating income: 126162000
Net income: 96847000
Capital expenditures: 14421000
Operating cash flow: 112861000
Depreciation & amortization: 46016000
Net tangible assets: 575198000
Owner earnings: 128442000
Return on net tangible assets (%): 22.330049826320675
Capex to operating income (%): 11.430541684500879
Buffett classification: The Great
Stock price: 32.05
P/E ratio: 15.611943285285037
Shares outstanding: 47175347
Book value: 928841000
P/B ratio: 1.6278026824289624
Market cap (USD): 1511969871.35
Debt to equity: 0.10570592814055366
Current ratio: 4.754407230593267
Quick ratio: 3.6967899945298126
Effective tax rate (%): 23.571005800418263
Interest coverage ratio: 30.203974144122576
COGS to revenue (%): 52.83737811817538
R&D to revenue (%): 11.391713573867307
SG&A to revenue (%): 16.165605487373504
Free cash flow (dilution-adjusted): 83173000
Buyback yield (%): 3.3544980598531557
Retained earnings: 290402000
Inventory turnover: 2.5240770890026507
Receivables turnover: 4.614159683902173
Capitalized R&D asset: 92589000
ROCI (R&D-adjusted, %): 16.209384444036093
FCF margin (%): 10.233213373934975
Rule of 40 score: 10.233213373934975
Financial ratios for COHU — annual report dated 2023-12-31
Total revenue: 636322000
Gross profit: 302868000
Operating income: 45693000
Net income: 28156000
Capital expenditures: 15837000
Operating cash flow: 101470000
Depreciation & amortization: 49744000
Net tangible assets: 556742000
Owner earnings: 62063000
Return on net tangible assets (%): 11.147533327825098
Capex to operating income (%): 34.65957586501215
Buffett classification: The Good
Stock price: 35.39
P/E ratio: 59.29590603530331
Shares outstanding: 47175347
Book value: 950170000
P/B ratio: 1.7570913945188755
Market cap (USD): 1669535530.33
Debt to equity: 0.05662355157498132
Current ratio: 6.176869301205751
Quick ratio: 4.6704731147445875
Effective tax rate (%): 38.54548629299808
Interest coverage ratio: 13.510644589000592
COGS to revenue (%): 52.40334296158235
R&D to revenue (%): 13.919210714072436
SG&A to revenue (%): 20.78334553889383
Free cash flow (dilution-adjusted): 68180000
Buyback yield (%): 1.4160225745736077
Retained earnings: 318558000
Inventory turnover: 2.1403657417213866
Receivables turnover: 5.105934651431506
Capitalized R&D asset: 150605630
ROCI (R&D-adjusted, %): 6.169108441662727
Rosenberg metric: -0.8689801164285175
FCF margin (%): 10.714701047582828
Revenue growth (%): -21.709944326535634
Rule of 40 score: -10.995243278952806
Financial ratios for COHU — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 25.7
Shares outstanding: 47175347
Market cap (USD): 1212406417.8999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COHU — annual report dated 2024-12-31
Total revenue: 401779000
Gross profit: 180294000
Operating income: -71627000
Net income: -69818000
Capital expenditures: 10527000
Operating cash flow: 2778000
Depreciation & amortization: 52487000
Net tangible assets: 511535000
Owner earnings: -27858000
Return on net tangible assets (%): -5.44596166440224
Buffett classification: The Gruesome
Stock price: 26.7
Shares outstanding: 47175347
Book value: 856891000
P/B ratio: 1.469943977588748
Market cap (USD): 1259581764.8999999
Debt to equity: 0.021814909947706303
Current ratio: 6.272386833208114
Quick ratio: 4.607038880540947
Interest coverage ratio: -115.90129449838187
COGS to revenue (%): 55.126076773549634
R&D to revenue (%): 21.105383805524927
SG&A to revenue (%): 31.867519208320992
Free cash flow (dilution-adjusted): -28596000
Buyback yield (%): 2.142457183170039
Retained earnings: 248740000
Inventory turnover: 1.561281818117735
Receivables turnover: 4.385324004846156
Capitalized R&D asset: 174693940
ROCI (R&D-adjusted, %): -6.931821520529535
Rosenberg metric: -1.3839066963227242
FCF margin (%): -7.117345605419895
Revenue growth (%): -36.859168785614834
Rule of 40 score: -43.976514391034726
Financial ratios for COHU — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 26.7
Shares outstanding: 47175347
Market cap (USD): 1259581764.8999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for COHU — quarterly report dated 2025-03-31
Total revenue: 96797000
Gross profit: 42317000
Operating income: -20698000
Net income: -30804000
Capital expenditures: 10962000
Operating cash flow: -10182000
Depreciation & amortization: 13084000
Net tangible assets: 450371000
Owner earnings: -28682000
Return on net tangible assets (%): -6.3685272808417945
Buffett classification: The Gruesome
Stock price: 14.71
Shares outstanding: 47175347
Book value: 827717000
P/B ratio: 0.8383896360350216
Market cap (USD): 693949354.37
Debt to equity: 0.03248815718415835
Current ratio: 5.202577588455186
Quick ratio: 3.6881357037294618
Interest coverage ratio: -104.53535353535354
COGS to revenue (%): 56.282736035207705
R&D to revenue (%): 23.9180966352263
SG&A to revenue (%): 31.004060043183156
Free cash flow (dilution-adjusted): -27376000
Buyback yield (%): 1.5273448895448967
Retained earnings: 217936000
Inventory turnover: 0.3909159401571413
Receivables turnover: 1.033890882679655
Capitalized R&D asset: 23152000
ROCI (R&D-adjusted, %): -0.5805157730069357
FCF margin (%): -28.28186823971817
Rule of 40 score: -28.28186823971817
Financial ratios for COHU — quarterly report dated 2025-06-30
Total revenue: 107680000
Gross profit: 47109000
Operating income: -16026000
Net income: -16880000
Capital expenditures: 2625000
Operating cash flow: 16047000
Depreciation & amortization: 13458000
Net tangible assets: 451300000
Owner earnings: -6047000
Return on net tangible assets (%): -1.33990693551961
Buffett classification: The Gruesome
Stock price: 19.24
Shares outstanding: 47175347
Book value: 830543000
P/B ratio: 1.092843689345404
Market cap (USD): 907653676.28
Debt to equity: 0.060742189146136924
Current ratio: 4.882543628498981
Quick ratio: 3.5119773280962563
Interest coverage ratio: -127.19047619047619
COGS to revenue (%): 56.25092867756315
R&D to revenue (%): 21.534175334323923
SG&A to revenue (%): 27.73588410104012
Free cash flow (dilution-adjusted): 7713000
Buyback yield (%): 0.16526127081286326
Retained earnings: 201056000
Inventory turnover: 0.4394584672533755
Receivables turnover: 1.1855636051350935
Capitalized R&D asset: 38699840
ROCI (R&D-adjusted, %): -0.8736078724280273
Rosenberg metric: 0.20697995853489978
FCF margin (%): 7.162890044576523
Revenue growth (%): 11.243117038751201
Rule of 40 score: 18.406007083327722
Financial ratios for COHU — quarterly report dated 2025-09-30
Total revenue: 126249000
Gross profit: 55264000
Operating income: -9207000
Net income: -4101000
Capital expenditures: 3917000
Operating cash flow: -14009000
Depreciation & amortization: 13593000
Net tangible assets: 462354000
Owner earnings: 5575000
Buffett classification: The Gruesome
Stock price: 20.33
Shares outstanding: 47175347
Book value: 831089000
P/B ratio: 1.1539977120500933
Market cap (USD): 959074804.5099999
Debt to equity: 0.06003929783693443
Current ratio: 4.392329273299576
Quick ratio: 3.244063911317914
Interest coverage ratio: -83.7
COGS to revenue (%): 56.226187930201434
R&D to revenue (%): 17.785487409801267
SG&A to revenue (%): 25.162971587893768
Free cash flow (dilution-adjusted): -23628000
Buyback yield (%): 0.006464563526061595
Retained earnings: 196955000
Inventory turnover: 0.5287680824754555
Receivables turnover: 1.0189999596432462
Capitalized R&D asset: 45630120
ROCI (R&D-adjusted, %): -1.0194151837584553
Rosenberg metric: 0.3516905295842677
FCF margin (%): -18.715395765511015
Revenue growth (%): 17.24461367013373
Rule of 40 score: -1.4707820953772845
Financial ratios for COHU — annual report dated 2025-12-31
Total revenue: 452956000
Gross profit: 193619000
Operating income: -59626000
Net income: -74273000
Capital expenditures: 20454000
Operating cash flow: 31692000
Depreciation & amortization: 50685000
Net tangible assets: 423240000
Owner earnings: -44042000
Return on net tangible assets (%): -10.405916265003308
Buffett classification: The Gruesome
Stock price: 23.27
Shares outstanding: 47175347
Book value: 785539000
P/B ratio: 1.3974739951676491
Market cap (USD): 1097770324.69
Debt to equity: 0.41725490395766474
Current ratio: 6.875721960431984
Quick ratio: 5.69302700819597
Interest coverage ratio: -29.02921129503408
COGS to revenue (%): 57.254347000591665
R&D to revenue (%): 20.358048022324464
SG&A to revenue (%): 27.279912397672177
Free cash flow (dilution-adjusted): -12308000
Buyback yield (%): 0.7821308161545181
Retained earnings: 174467000
Inventory turnover: 2.0102708401159637
Receivables turnover: 4.164959449767365
Capitalized R&D asset: 178255420
ROCI (R&D-adjusted, %): -4.263201494220877
Rosenberg metric: 0.15713999316013538
FCF margin (%): -2.717261720785242
Revenue growth (%): 12.737599526107637
Rule of 40 score: 10.020337805322395
Financial ratios for COHU — quarterly report dated 2025-12-31
Total revenue: 122230000
Gross profit: 48929000
Operating income: -13695000
Net income: -22488000
Capital expenditures: 2950000
Operating cash flow: 39836000
Depreciation & amortization: 10550000
Net tangible assets: 423240000
Owner earnings: -14888000
Return on net tangible assets (%): -3.517625933276628
Buffett classification: The Gruesome
Stock price: 23.27
Shares outstanding: 47175347
Book value: 785539000
P/B ratio: 1.3974739951676491
Market cap (USD): 1097770324.69
Debt to equity: 0.41725490395766474
Current ratio: 6.875721960431984
Quick ratio: 5.69302700819597
Interest coverage ratio: -8.453703703703704
COGS to revenue (%): 59.96972919905097
R&D to revenue (%): 19.159780741225557
SG&A to revenue (%): 26.115519921459544
Free cash flow (dilution-adjusted): 30983000
Buyback yield (%): 0.05237889812355555
Retained earnings: 174467000
Inventory turnover: 0.5681983783699983
Receivables turnover: 1.1239126836714053
Capitalized R&D asset: 46115220
ROCI (R&D-adjusted, %): -1.1267895563034416
Rosenberg metric: -0.28213235949051396
FCF margin (%): 25.348114210913852
Revenue growth (%): -3.1833915516162508
Rule of 40 score: 22.164722659297603
Financial ratios for CTS — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 36.12
Shares outstanding: 28592910
Market cap (USD): 1032775909.1999999
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTS — annual report dated 2022-12-31
Total revenue: 586869000
Gross profit: 210538000
Operating income: 94918000
Net income: 59575000
Capital expenditures: 14333000
Operating cash flow: 121197000
Depreciation & amortization: 29753000
Net tangible assets: 245810000
Owner earnings: 74995000
Return on net tangible assets (%): 30.509336479394655
Capex to operating income (%): 15.100402452643335
Buffett classification: The Great
Stock price: 38.94
P/E ratio: 18.689180283676038
Shares outstanding: 28592910
Book value: 506224000
P/B ratio: 2.199437236085211
Market cap (USD): 1113407915.3999999
Debt to equity: 0.21603084800404565
Current ratio: 2.894821028685174
Quick ratio: 2.3415561795755875
Effective tax rate (%): 26.21103087803609
Interest coverage ratio: 43.30200729927007
COGS to revenue (%): 64.125213633707
R&D to revenue (%): 4.106538256408159
SG&A to revenue (%): 15.594621627654554
Free cash flow (dilution-adjusted): 99138000
Buyback yield (%): 1.9262482063723256
Retained earnings: 546703000
Inventory turnover: 6.044506906521041
Receivables turnover: 6.4537196898883815
Capitalized R&D asset: 24100000
ROCI (R&D-adjusted, %): 16.81445738107683
FCF margin (%): 16.89269666654739
Rule of 40 score: 16.89269666654739
Financial ratios for CTS — annual report dated 2023-12-31
Total revenue: 550422000
Gross profit: 190859000
Operating income: 82125000
Net income: 60532000
Capital expenditures: 14738000
Operating cash flow: 88811000
Depreciation & amortization: 28710000
Net tangible assets: 265227000
Owner earnings: 74504000
Return on net tangible assets (%): 28.090654420552962
Capex to operating income (%): 17.945814307458143
Buffett classification: The Great
Stock price: 43.37
P/E ratio: 20.486263574638205
Shares outstanding: 28592910
Book value: 526822000
P/B ratio: 2.3538776032511928
Market cap (USD): 1240074506.6999998
Debt to equity: 0.18385526800323448
Current ratio: 3.290934572697575
Quick ratio: 2.6723070105833737
Effective tax rate (%): 19.454978510505235
Interest coverage ratio: 24.654758330831584
COGS to revenue (%): 65.32496884208844
R&D to revenue (%): 4.527071955699445
SG&A to revenue (%): 15.227589013520534
Free cash flow (dilution-adjusted): 68892000
Buyback yield (%): 3.300285569849301
Retained earnings: 602232000
Inventory turnover: 5.989622028618547
Receivables turnover: 7.005587445430131
Capitalized R&D asset: 41065000
ROCI (R&D-adjusted, %): 13.237681451308852
Rosenberg metric: -0.8165560165975104
FCF margin (%): 12.516214831529263
Revenue growth (%): -6.210414930759676
Rule of 40 score: 6.305799900769587
Financial ratios for CTS — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 48.09
Shares outstanding: 28592910
Market cap (USD): 1375033041.9
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTS — annual report dated 2024-12-31
Total revenue: 514756000
Gross profit: 187555000
Operating income: 75882000
Net income: 55472000
Capital expenditures: 18644000
Operating cash flow: 98242000
Depreciation & amortization: 30922000
Net tangible assets: 163022000
Owner earnings: 67750000
Return on net tangible assets (%): 41.55880801364233
Capex to operating income (%): 24.56972668089929
Buffett classification: The Great
Stock price: 52.46
P/E ratio: 27.04038178901067
Shares outstanding: 28592910
Book value: 528208000
P/B ratio: 2.8397602054493687
Market cap (USD): 1499984058.6000001
Debt to equity: 0.2236599975767122
Current ratio: 2.4595431786559416
Quick ratio: 1.9282573149304816
Effective tax rate (%): 19.114623583791428
Interest coverage ratio: 17.913597733711047
COGS to revenue (%): 63.564290654212876
R&D to revenue (%): 4.543511877472045
SG&A to revenue (%): 17.150844283505194
Free cash flow (dilution-adjusted): 73948000
Buyback yield (%): 2.839763513204046
Retained earnings: 652851000
Inventory turnover: 6.2547981342712955
Receivables turnover: 6.629267601643292
Capitalized R&D asset: 48036060
ROCI (R&D-adjusted, %): 10.508344106525904
Rosenberg metric: -0.13259491130909382
FCF margin (%): 14.365641196994305
Revenue growth (%): -6.479755533027386
Rule of 40 score: 7.88588566396692
Financial ratios for CTS — quarterly report dated 2024-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 52.46
Shares outstanding: 28592910
Market cap (USD): 1499984058.6000001
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CTS — quarterly report dated 2025-03-31
Total revenue: 125769000
Gross profit: 46549000
Operating income: 16736000
Net income: 13367000
Capital expenditures: 4465000
Operating cash flow: 15518000
Depreciation & amortization: 8494000
Net tangible assets: 172949000
Owner earnings: 17396000
Return on net tangible assets (%): 10.058456539210981
Capex to operating income (%): 26.679015296367115
Buffett classification: The Good
Stock price: 41.37
P/E ratio: 22.123301539238422
Shares outstanding: 28592910
Book value: 538238000
P/B ratio: 2.1977056370973433
Market cap (USD): 1182888686.6999998
Debt to equity: 0.20845611049387075
Current ratio: 2.6347339723478376
Quick ratio: 2.0517991215353657
Effective tax rate (%): 17.0884505644461
Interest coverage ratio: 14.341045415595545
COGS to revenue (%): 62.988494780112745
R&D to revenue (%): 4.921721568908078
SG&A to revenue (%): 18.78284791959863
Free cash flow (dilution-adjusted): 9406000
Buyback yield (%): 0.5465433960684782
Retained earnings: 665017000
Inventory turnover: 1.4702225191618878
Receivables turnover: 1.544314833005894
Capitalized R&D asset: 6190000
ROCI (R&D-adjusted, %): 3.0712730855822703
FCF margin (%): 7.478790480961127
Rule of 40 score: 7.478790480961127
Financial ratios for CTS — quarterly report dated 2025-06-30
Total revenue: 135309000
Gross profit: 52431000
Operating income: 23028000
Net income: 18527000
Capital expenditures: 3280000
Operating cash flow: 28352000
Depreciation & amortization: 8551000
Net tangible assets: 180825000
Owner earnings: 23798000
Return on net tangible assets (%): 13.16079081985345
Capex to operating income (%): 14.243529616119508
Buffett classification: The Great
Stock price: 42.47
P/E ratio: 38.07427377249639
Shares outstanding: 28592910
Book value: 550157000
P/B ratio: 2.2072624499915476
Market cap (USD): 1214340887.7
Debt to equity: 0.20458887190383837
Current ratio: 2.6053590269344853
Quick ratio: 2.0369776839925944
Effective tax rate (%): 19.384735880254112
Interest coverage ratio: 20.54237288135593
COGS to revenue (%): 61.25091457330998
R&D to revenue (%): 4.675224855700655
SG&A to revenue (%): 17.055036989409427
Free cash flow (dilution-adjusted): 24456000
Buyback yield (%): 1.3612322674326105
Retained earnings: 682360000
Inventory turnover: 1.4513773356916448
Receivables turnover: 1.5811189791768911
Capitalized R&D asset: 10473300
ROCI (R&D-adjusted, %): 3.6246846465342317
Rosenberg metric: 0.9502423263327948
FCF margin (%): 18.074185752610692
Revenue growth (%): 7.585335018963338
Rule of 40 score: 25.65952077157403
Financial ratios for CTS — quarterly report dated 2025-09-30
Total revenue: 142970000
Gross profit: 55341000
Operating income: 21218000
Net income: 13687000
Capital expenditures: 4797000
Operating cash flow: 29023000
Depreciation & amortization: 8835000
Net tangible assets: 182961000
Owner earnings: 17725000
Return on net tangible assets (%): 9.68785697498374
Capex to operating income (%): 22.608162880573097
Buffett classification: The Great
Stock price: 39.85
P/E ratio: 24.99786015006253
Shares outstanding: 28592910
Book value: 547654000
P/B ratio: 2.0805608349432307
Market cap (USD): 1139427463.5
Debt to equity: 0.21387226241385984
Current ratio: 2.6360408513887563
Quick ratio: 2.118278133053355
Effective tax rate (%): 30.59330628803246
Interest coverage ratio: 19.115315315315314
COGS to revenue (%): 61.29187941526194
R&D to revenue (%): 4.826886759460026
SG&A to revenue (%): 19.0403581170875
Free cash flow (dilution-adjusted): 23057000
Buyback yield (%): 1.4525716230465424
Retained earnings: 694881000
Inventory turnover: 1.6154002138406518
Receivables turnover: 1.6649780479567713
Capitalized R&D asset: 13182120
ROCI (R&D-adjusted, %): 3.097766108984812
Rosenberg metric: 0.4600063231109706
FCF margin (%): 16.12715954396027
Revenue growth (%): 5.66185545676932
Rule of 40 score: 21.78901500072959
Financial ratios for CTS — annual report dated 2025-12-31
Total revenue: 541318000
Gross profit: 208026000
Operating income: 84038000
Net income: 65317000
Capital expenditures: 15731000
Operating cash flow: 102105000
Depreciation & amortization: 34538000
Net tangible assets: 188613000
Owner earnings: 84124000
Return on net tangible assets (%): 44.601379544358025
Capex to operating income (%): 18.718912872748042
Buffett classification: The Great
Stock price: 42.81
P/E ratio: 18.740335243504756
Shares outstanding: 28592910
Book value: 551786000
P/B ratio: 2.218364505623557
Market cap (USD): 1224062477.1000001
Debt to equity: 0.15004730094638138
Current ratio: 2.3038618627379477
Quick ratio: 1.8220042301801473
Effective tax rate (%): 22.029103150254862
Interest coverage ratio: 19.502900905082384
COGS to revenue (%): 61.57046320277545
R&D to revenue (%): 4.6678662080329865
SG&A to revenue (%): 18.23696976638501
Free cash flow (dilution-adjusted): 81485000
Buyback yield (%): 4.589471620198233
Retained earnings: 713467000
Inventory turnover: 6.305899269686305
Receivables turnover: 6.144637667998547
Capitalized R&D asset: 49160900
ROCI (R&D-adjusted, %): 12.046500826934707
Rosenberg metric: 0.875277920301009
FCF margin (%): 15.053074163430738
Revenue growth (%): 5.160114695117687
Rule of 40 score: 20.213188858548424
Financial ratios for CTS — quarterly report dated 2025-12-31
Total revenue: 137271000
Gross profit: 53706000
Operating income: 23056000
Net income: 19736000
Capital expenditures: 3189000
Operating cash flow: 29212000
Depreciation & amortization: 8658000
Net tangible assets: 188613000
Owner earnings: 25205000
Return on net tangible assets (%): 13.363341869330322
Capex to operating income (%): 13.831540596807773
Buffett classification: The Great
Stock price: 42.81
P/E ratio: 18.740335243504756
Shares outstanding: 28592910
Book value: 551786000
P/B ratio: 2.218364505623557
Market cap (USD): 1224062477.1000001
Debt to equity: 0.15004730094638138
Current ratio: 2.3038618627379477
Quick ratio: 1.8220042301801473
Effective tax rate (%): 20.888283160299835
Interest coverage ratio: 25.308452250274424
COGS to revenue (%): 60.87593155145661
R&D to revenue (%): 4.263099999271514
SG&A to revenue (%): 18.064995519811177
Free cash flow (dilution-adjusted): 24566000
Buyback yield (%): 1.3587541740029372
Retained earnings: 713467000
Inventory turnover: 1.5810534680440458
Receivables turnover: 1.558197875045405
Capitalized R&D asset: 12563250
ROCI (R&D-adjusted, %): 3.379616011770826
Rosenberg metric: -0.23692218519055208
FCF margin (%): 17.895986770694467
Revenue growth (%): -3.9861509407568025
Rule of 40 score: 13.909835829937665
Financial ratios for CYN — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 67500
Shares outstanding: 14423281
Market cap (USD): 973571467500
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYN — annual report dated 2022-12-31
Total revenue: 262000
Gross profit: 75177
Operating income: -19400727
Net income: -19236509
Capital expenditures: 918318
Operating cash flow: -16299223
Depreciation & amortization: 604871
Net tangible assets: 23644451
Owner earnings: -19549956
Return on net tangible assets (%): -82.68306166212106
Buffett classification: The Gruesome
Stock price: 10110
Shares outstanding: 14423281
Book value: 24117527
P/B ratio: 6046.199136005943
Market cap (USD): 145819370910
Debt to equity: 0.015616111884108184
Current ratio: 17.136579494553093
Quick ratio: 17.08844924449634
COGS to revenue (%): 71.30648854961832
R&D to revenue (%): 3618.82786259542
SG&A to revenue (%): 3814.7232824427483
Free cash flow (dilution-adjusted): -20542061
Buyback yield (%): 0
Retained earnings: -135730039
Inventory turnover: 2.797589098532495
Receivables turnover: 1.2420358009708738
Capitalized R&D asset: 9481329
ROCI (R&D-adjusted, %): -38.92942366847252
FCF margin (%): -7840.481297709924
Rule of 40 score: -7840.481297709924
Financial ratios for CYN — annual report dated 2023-12-31
Total revenue: 1489317
Gross profit: 266996
Operating income: -23345942
Net income: -22811230
Capital expenditures: 1045822
Operating cash flow: -19477605
Depreciation & amortization: 961281
Net tangible assets: 9550774
Owner earnings: -22895771
Return on net tangible assets (%): -239.72686402170126
Buffett classification: The Gruesome
Stock price: 2175
Shares outstanding: 14423281
Book value: 10635189
P/B ratio: 2949.7018036068753
Market cap (USD): 31370636175
Debt to equity: 0.09403330772965107
Current ratio: 4.551072820706038
Quick ratio: 4.551072820706038
COGS to revenue (%): 82.0725876358089
R&D to revenue (%): 854.0816360788201
SG&A to revenue (%): 731.4060740594514
Free cash flow (dilution-adjusted): -24450241
Buyback yield (%): 0
Retained earnings: -160017619
Receivables turnover: 1.9211465604090694
Capitalized R&D asset: 19072473.43
ROCI (R&D-adjusted, %): -60.037943290236726
Rosenberg metric: 0.02023123551561179
FCF margin (%): -1641.7083132738028
Revenue growth (%): 468.4416030534351
Rule of 40 score: -1173.2667102203677
Financial ratios for CYN — quarterly report dated 2024-09-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 583.5
Shares outstanding: 14423281
Market cap (USD): 8415984463.5
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYN — annual report dated 2024-12-31
Total revenue: 368138
Gross profit: -167570
Operating income: -22828075
Net income: -33335579
Capital expenditures: 1051481
Operating cash flow: -19196081
Depreciation & amortization: 669409
Net tangible assets: -2942990
Owner earnings: -33717651
Buffett classification: The Gruesome
Stock price: 127.35
Shares outstanding: 14423281
Book value: -1047916
Market cap (USD): 1836804835.35
Debt to equity: -0.3028334332141126
Current ratio: 7.438336970661214
Quick ratio: 7.394653854898821
COGS to revenue (%): 145.51825674067877
R&D to revenue (%): 3058.538102559366
SG&A to revenue (%): 3096.899532240627
Free cash flow (dilution-adjusted): -23650982
Buyback yield (%): 0
Retained earnings: -193353198
Inventory turnover: 3.5656578430654746
Receivables turnover: 0.3010390950624381
Capitalized R&D asset: 22910868.18
ROCI (R&D-adjusted, %): -45.841266135569526
Rosenberg metric: -0.0341640393701784
FCF margin (%): -6424.488099571356
Revenue growth (%): -75.28142094664871
Rule of 40 score: -6499.769520518004
Financial ratios for CYN — quarterly report dated 2024-12-31
Capital expenditures: 725007
Buffett classification: The Gruesome
Stock price: 127.35
Shares outstanding: 14423281
Market cap (USD): 1836804835.35
Buyback yield (%): 0
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for CYN — quarterly report dated 2025-03-31
Total revenue: 47152
Gross profit: 35339
Operating income: -5215033
Net income: -3911647
Capital expenditures: 178453
Operating cash flow: -6513068
Depreciation & amortization: 240907
Net tangible assets: 19599587
Owner earnings: -3849193
Return on net tangible assets (%): -19.639153620941094
Buffett classification: The Gruesome
Stock price: 4.53
Shares outstanding: 14423281
Book value: 22142905
P/B ratio: 2.9507177549648524
Market cap (USD): 65337462.93000001
Debt to equity: 0.005761303677182375
Current ratio: 8.48856732054111
Quick ratio: 8.079633947560708
COGS to revenue (%): 25.05302002035969
R&D to revenue (%): 4468.3364438411945
SG&A to revenue (%): 6666.6567695962
Free cash flow (dilution-adjusted): -7883339
Buyback yield (%): 0
Retained earnings: -196862745
Inventory turnover: 0.013094115130226201
Receivables turnover: 0.05206121653566346
Capitalized R&D asset: 2106910
ROCI (R&D-adjusted, %): -15.713218155822359
FCF margin (%): -16718.99177129284
Rule of 40 score: -16718.99177129284
Financial ratios for CYN — quarterly report dated 2025-06-30
Total revenue: 33726
Gross profit: 16782
Operating income: -5501865
Net income: -5448312
Capital expenditures: 174400
Operating cash flow: -6257295
Depreciation & amortization: 362209
Net tangible assets: 43697352
Owner earnings: -5260503
Return on net tangible assets (%): -12.038493774176521
Buffett classification: The Gruesome
Stock price: 14.4
Shares outstanding: 14423281
Book value: 46763158
P/B ratio: 4.441429006997346
Market cap (USD): 207695246.4
Debt to equity: 0.14156618763856796
Current ratio: 14.543733892933757
Quick ratio: 14.215185738721887
COGS to revenue (%): 50.24017078811599
R&D to revenue (%): 5841.5614066299
SG&A to revenue (%): 10521.621301073355
Free cash flow (dilution-adjusted): -7419667
Buyback yield (%): 0
Retained earnings: -202311057
Inventory turnover: 0.017189430691411982
Receivables turnover: 0.029493298726556913
Capitalized R&D asset: 3381754.7
ROCI (R&D-adjusted, %): -8.646643068919252
Rosenberg metric: -0.008807685188261482
FCF margin (%): -21999.842851212714
Revenue growth (%): -28.473871733966742
Rule of 40 score: -22028.31672294668
Financial ratios for CYN — quarterly report dated 2025-09-30
Total revenue: 69973
Gross profit: 19157
Operating income: -8417000
Net income: -8438641
Capital expenditures: 519516
Operating cash flow: -4065179
Depreciation & amortization: 291196
Net tangible assets: 38208592
Owner earnings: -8666961
Return on net tangible assets (%): -22.683277625095425
Buffett classification: The Gruesome
Stock price: 6.03
Shares outstanding: 14423281
Book value: 38679373
P/B ratio: 2.24854690457366
Market cap (USD): 86972384.43
Debt to equity: 0.1735601298397469
Current ratio: 9.990302495174255
Quick ratio: 9.763937399136108
COGS to revenue (%): 72.62229717176625
R&D to revenue (%): 7509.972417932631
SG&A to revenue (%): 4546.3307275663465
Free cash flow (dilution-adjusted): -4943505
Buyback yield (%): 0
Retained earnings: -211151798
Inventory turnover: 0.057386657511784275
Receivables turnover: 0.0483764810643614
Capitalized R&D asset: 7270217.05
ROCI (R&D-adjusted, %): -11.919452355350314
Rosenberg metric: 0.001205507264767464
FCF margin (%): -7064.875023223243
Revenue growth (%): 107.47494514617802
Rule of 40 score: -6957.400078077066
Financial ratios for CYN — annual report dated 2025-12-31
Total revenue: 218976
Gross profit: 83227
Operating income: -25688241
Net income: -23469273
Capital expenditures: 1230536
Operating cash flow: -23576656
Depreciation & amortization: 1189794
Net tangible assets: 38288183
Owner earnings: -23510015
Return on net tangible assets (%): -61.40279626223057
Buffett classification: The Gruesome
Stock price: 2.38
Shares outstanding: 14423281
Book value: 38754406
P/B ratio: 0.8857678990099861
Market cap (USD): 34327408.78
Debt to equity: 0.17566056876216862
Current ratio: 8.291448434107004
Quick ratio: 7.866834611796726
COGS to revenue (%): 61.992638462662576
R&D to revenue (%): 5694.088393248576
SG&A to revenue (%): 6074.994976618442
Free cash flow (dilution-adjusted): -26457245
Buyback yield (%): 0
Retained earnings: -216822471
Inventory turnover: 0.06655488305620313
Receivables turnover: 0.14180427182001445
Capitalized R&D asset: 24210240.86
ROCI (R&D-adjusted, %): -36.52321692866819
Rosenberg metric: 0.022273978362187568
FCF margin (%): -12082.257873008915
Revenue growth (%): -40.51795793968566
Rule of 40 score: -12122.775830948602
Financial ratios for CYN — quarterly report dated 2025-12-31
Total revenue: 68125
Gross profit: 11950
Operating income: -6554343
Net income: -5670673
Capital expenditures: 358167
Operating cash flow: -6741114
Depreciation & amortization: 295482
Net tangible assets: 38288183
Owner earnings: -5733358
Return on net tangible assets (%): -14.974223247940493
Buffett classification: The Gruesome
Stock price: 2.38
Shares outstanding: 14423281
Book value: 38754406
P/B ratio: 0.8857678990099861
Market cap (USD): 34327408.78
Debt to equity: 0.17566056876216862
Current ratio: 8.291448434107004
Quick ratio: 7.866834611796726
COGS to revenue (%): 82.45871559633028
R&D to revenue (%): 4604.3302752293575
SG&A to revenue (%): 5034.26495412844
Free cash flow (dilution-adjusted): -6210734
Buyback yield (%): 0
Retained earnings: -216822471
Inventory turnover: 0.02754142244644315
Receivables turnover: 0.04411632333104306
Capitalized R&D asset: 7307659.76
ROCI (R&D-adjusted, %): -13.074427634228828
Rosenberg metric: -0.0013714680226445412
FCF margin (%): -9116.67376146789
Revenue growth (%): -2.641018678633187
Rule of 40 score: -9119.314780146522
Financial ratios for DOM.MC — annual report dated 2021-12-31
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 4.693181818181818
Shares outstanding: 150014632
Market cap (USD): 704045943.3636364
Buyback yield (%): 3.753144789120081
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DOM.MC — annual report dated 2022-12-31
Total revenue: 1305817021.2765958
Gross profit: 330362765.9574468
Operating income: 84732978.72340426
Net income: 38287234.042553194
Capital expenditures: 34415957.44680851
Operating cash flow: 101696808.5106383
Depreciation & amortization: 51561702.127659574
Net tangible assets: -125334042.5531915
Owner earnings: 55432978.723404266
Return on net tangible assets (%): -44.22819019810889
Capex to operating income (%): 40.61695689839169
Buffett classification: The Good
Stock price: 3.4361702127659575
P/E ratio: 13.463385978327311
Shares outstanding: 150014632
Book value: 326736170.21276593
P/B ratio: 1.577651502806611
Market cap (USD): 515475809.9574468
Debt to equity: 1.2942057486683252
Current ratio: 0.8131058553370117
Quick ratio: 0.7411208255173194
Effective tax rate (%): 20.911220860653664
Interest coverage ratio: 12.221727788859905
COGS to revenue (%): 74.70068466143313
SG&A to revenue (%): 4.017294137199504
Free cash flow (dilution-adjusted): 60534042.55319149
Buyback yield (%): 5.658065205662357
Retained earnings: 120289361.70212767
Inventory turnover: 11.64425677820814
Receivables turnover: 5.045971955586067
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 12.083794161777714
FCF margin (%): 4.6357216644344295
Rule of 40 score: 4.6357216644344295
Financial ratios for DOM.MC — annual report dated 2023-12-31
Total revenue: 1337744444.4444444
Gross profit: 376735555.5555555
Operating income: 93995555.55555555
Net income: 50342222.222222224
Capital expenditures: 49474444.44444444
Operating cash flow: 86512222.22222222
Depreciation & amortization: 75046666.66666667
Net tangible assets: -127358888.88888888
Owner earnings: 75914444.44444445
Return on net tangible assets (%): -59.6067106950612
Capex to operating income (%): 52.63487635349189
Buffett classification: The Good
Stock price: 3.4444444444444446
P/E ratio: 10.264089326388275
Shares outstanding: 150014632
Book value: 351113333.33333325
P/B ratio: 1.471653214853071
Market cap (USD): 516717065.7777778
Debt to equity: 1.1497712039797219
Current ratio: 0.8403868604967296
Quick ratio: 0.741097730652977
Effective tax rate (%): 2.000219322294111
Interest coverage ratio: 1.752449609512564
COGS to revenue (%): 71.8380026080384
SG&A to revenue (%): 2.8972482703057385
Free cash flow (dilution-adjusted): 27945555.555555556
Buyback yield (%): 1.8056303183941116
Retained earnings: 277345555.5555555
Inventory turnover: 6.965571116784383
Receivables turnover: 5.5157390312398356
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 14.262808894613762
FCF margin (%): 2.0890055400051497
Revenue growth (%): 2.4450150861592865
Rule of 40 score: 4.534020626164436
Financial ratios for DOM.MC — annual report dated 2024-12-31
Total revenue: 1201000000
Gross profit: 328725000
Operating income: 91978125
Net income: 34892708.333333336
Capital expenditures: 46490625
Operating cash flow: 55178125
Depreciation & amortization: 69177083.33333334
Net tangible assets: -122241666.66666667
Owner earnings: 57579166.66666669
Return on net tangible assets (%): -47.102733656009285
Capex to operating income (%): 50.54530628885945
Buffett classification: The Good
Stock price: 2.7708333333333335
P/E ratio: 11.912676392512763
Shares outstanding: 150014632
Book value: 325806250
P/B ratio: 1.275805920952509
Market cap (USD): 415665542.8333334
Debt to equity: 1.44371335213285
Current ratio: 0.888485329634677
Quick ratio: 0.7691460306068758
Effective tax rate (%): 14.289464119856238
Interest coverage ratio: 1.6735339827906446
COGS to revenue (%): 72.62905911740216
SG&A to revenue (%): 3.1477241187898977
Free cash flow (dilution-adjusted): 8109375
Buyback yield (%): 0
Retained earnings: 266904166.6666667
Inventory turnover: 6.523003100316263
Receivables turnover: 8.848299732162728
Capitalized R&D asset: 0
ROCI (R&D-adjusted, %): 13.085850375018342
FCF margin (%): 0.6752185678601166
Revenue growth (%): -10.22201549872505
Rule of 40 score: -9.546796930864932
Financial ratios for DOM.MC — quarterly report dated 2024-12-31
Capital expenditures: 0
Net tangible assets: -122241666.66666667
Buffett classification: The Gruesome
Stock price: 2.7708333333333335
Shares outstanding: 150014632
Book value: 325806250
P/B ratio: 1.275805920952509
Market cap (USD): 415665542.8333334
Debt to equity: 1.44371335213285
Current ratio: 0.888485329634677
Quick ratio: 0.7691460306068758
Buyback yield (%): 0
Retained earnings: 266904166.6666667
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DOM.MC — quarterly report dated 2025-06-30
Capital expenditures: 0
Net tangible assets: -180394117.6470588
Buffett classification: The Gruesome
Stock price: 3.5058823529411764
Shares outstanding: 150014632
Book value: 315187058.82352924
P/B ratio: 1.6686397372242077
Market cap (USD): 525933651.0117647
Debt to equity: 1.7357983494395492
Current ratio: 0.8295223339436869
Quick ratio: 0.7229027992966546
Buyback yield (%): 0
Retained earnings: 290927058.8235294
Capitalized R&D asset: 0
Rule of 40 score: 0
Financial ratios for DOW.AX — annual report dated 2021-06-30
Capital expenditures: 0
Buffett classification: The Gruesome
Stock price: 3.4887218045112776
Shares outstanding: 659010687
Market cap (USD): 2299104953.1428566
Buyback yield (%): 0.8110380744412566
Capitalized R&D asset: 0
Rule of 40 score: 0